GlycoMantra
Business Services · Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
24793 Shells Way, Aldie, Virginia, 20105...Phone Number
(301) 655-1084Website
www.glycomantra.comRevenue
<$5 MillionIndustry
About GlycoMantra
GlycoMantra is a biotechnology company focused on developing innovative therapeutics for unmet medical needs, specifically targeting metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes. The company specializes in glycobiology research, particularly in the role of galectin-3 in cancer progression and metastasis. Their aim is to create high-affinity carbohydrate-based drugs to address abnormal protein-carbohydrate interactions that contribute to various diseases. GlycoMantra is positioned to collaborate with partners and investors to advance their product pipeline and research initiatives.Explore more
GlycoMantra Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to GlycoMantra
Compare insights from companies similar to GlycoMantra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
GlycoMantra Tech Stack
A closer look at the technologies used by GlycoMantra
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding GlycoMantra
Sign Up For FreeTo access detailed company insights
GlycoMantra is a biotechnology company focused on developing innovative therapeutics for unmet medical needs, specifically targeting metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes. The company specializes in glycobiology research, particularly in the role of galectin-3 in cancer progression and metastasis.... Read More
